Czech Health Research Council
The Czech Health Research Council (AZV ČR) is an organisational component of the Czech Ministry of Health responsible for funding applied health research, distributing over 1 billion CZK annually across approximately 90 supported projects per year. It provided the primary grant for the PSIKET001 trial — a landmark double-blind comparison of psilocybin versus ketamine for treatment-resistant depression at the National Institute of Mental Health — with a total budget of 12 million CZK.
Foundations & Philanthropy Snapshot
Grant-Making OrganizationsClassification
Grant Program (Host Organization)
Geography
Global
Coverage
Global
Last Verified
Apr 10, 2026
Funding Focus Areas
Support Types
Philanthropy Notes
Auto-backfilled baseline philanthropy profile from existing category tags and website. Manual enrichment recommended for recipient-level details.
Verification
Verified
Psychedelic Focus
Psychedelic-Adjacent Focus
Engagement Status
Unknown
Verification Notes
Verified against official Czech health research funding council pages.
Quick Facts
- Type
- Other
- HQ
- Czechia
- Website
- Visit